Clinical Trials List
Protocol Number111482 [MAGE3-AS15-MEL-005 (ADJ)]
2010-09-15 - 2016-12-31
Phase III
Terminated3
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 楊志勛 Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHERNG-KANG PERNG Division of Plastic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊文祺 Division of Hematology & Oncology
- Su-Shin Lee Division of Plastic Surgery
- 陳國熏 Division of Dermatology
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
1300 participants
